Wilson Disease

Wilson’s disease is an autosomal recessive disorder caused by mutation in the ATP7B gene and is characterized by copper build-up in the body. Discover the latest research on Wilson’s disease here.

December 2, 2020
Open Access

The Role of the Gut Microbiome in Liver Fibrosis.

Na Young Lee, Ki Tae Suk
January 1, 2021
Open Access

The Role of the Gut Microbiome in Liver Cirrhosis Treatment

International Journal of Molecular Sciences
Na Young Lee, Ki Tae Suk
November 12, 2020

Effect of homeostatic iron regulator protein gene mutation on Wilson's disease clinical manifestation: original data and literature review

The International Journal of Neuroscience
Grażyna GromadzkaTomasz Litwin
October 17, 2020
Case Report
Open Access

IgA vasculitis with nephritis in cirrhotic Wilson disease: Is there an association?

Clinical Nephrology. Case Studies
Ratna AcharyaKiran Upadhyay
January 8, 2021
Case Report

Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson's disease: balancing immunosuppression

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Matthias LubnowDaniel Heudobler
November 8, 2020

Wilson disease: revision of diagnostic criteria in a clinical series with great genetic homogeneity

Journal of Gastroenterology
Luis García-VillarrealAntonio Tugores
November 20, 2020
Open Access

Golgi-Dependent Copper Homeostasis Sustains Synaptic Development and Mitochondrial Content

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Cortnie HartwigVictor Faundez
December 22, 2020
Case Report
Open Access

Elastosis Perforans Serpiginosa: a D-penicillamine induced dermatoses in a patient with Wilson's disease

Autopsy & Case Reports
Swagatika Samal, Mukund Sable
December 10, 2020
Open Access

Copper Dyshomeostasis in Neurodegenerative Diseases-Therapeutic Implications

International Journal of Molecular Sciences
Grażyna GromadzkaAgata Adamczyk
October 13, 2020
Open Access

Paramagnetic Metal Accumulation in the Deep Gray Matter Nuclei Is Associated With Neurodegeneration in Wilson's Disease

Frontiers in Neuroscience
Xiang-Zhen YuanXiao-Ping Wang
December 15, 2020
Open Access

Neurodegeneration in Hepatic and Neurologic Wilson Disease

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
André ViveirosChristoph Scherfler
October 21, 2020
Open Access

Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease

Movement Disorders : Official Journal of the Movement Disorder Society
Samuel ShribmanThomas T Warner
November 21, 2020

Wilson disease: Many guidelines but still many unsolved doubts

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Fabiola Di Dato, Raffaele Iorio
January 13, 2021

Hypopituitarism in Wilson's disease resolved after copper-chelating therapy

Endocrinology, Diabetes & Metabolism Case Reports
Nina DauthKlaus Badenhoop
January 5, 2021

Gynecological history up to diagnosis and pregnancy outcomes in diagnosed Wilson's disease under therapy - a bicentric matched control cohort study

Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva
Joana RoseiraFilipe Calinas
October 29, 2020
Open Access

Total and Exchangeable Copper Assay Using Inductively Coupled Plasma Mass Spectrometry and Establishment of a Pediatric Reference Interval

Archives of Pathology & Laboratory Medicine
Jisook YimSang-Guk Lee

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

4H Leukodystrophy

4H Lekodystrophy involves hypomyelination, hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. There is not yet a known cure.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

© 2021 Meta ULC. All rights reserved